Digital Diagnostics’ flagship product, LumineticsCore™, is the first FDA-cleared autonomous AI diagnostic system designed to detect diabetic retinopathy (including macular edema), a common complication of diabetes and a leading cause of blindness. LumineticsCore is modeled to look for and make decisions based on the same clinical disease detectors that eyecare specialists would use, enabling it to autonomously deliver a diagnosis at the point-of-care. By bringing high-quality diagnostic services to the point-of-care to meet patients where they are, LumineticsCore bridges the gap between specialty and primary care, delivering accessibility, affordability, equity, and high-quality healthcare globally, using technology.